{"product_id":"2023-2027-physician-office-diagnostics-forecasts-for-300-tests-2022-supplier-shares-and-strategies-instrumentation-review-emerging-technologies-opportunities-for-suppliers","title":"2023-2027 Physician Office Diagnostics Forecasts for 300 Tests: 2022 Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers","description":"\u003cp\u003e2023-2027 Physician Office Diagnostics Forecasts for 300 Tests: 2022 Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers\u003c\/p\u003e\n\n\u003cp\u003eThisreport provides a comprehensive analysis of the physician office\/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. The report is available by section, and can be customized to specific information needs and budget.\u003c\/p\u003e\n\n\u003cp\u003eThis report will help diagnostic reagent and instrument suppliers develop more effective business, R\u0026amp;D and marketing strategies.\u003c\/p\u003e\n\n\u003cp\u003eRationale\u003c\/p\u003e\n\n\u003cp\u003eThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e\n\n\u003cp\u003eReview of the physician office\/group practice diagnostics market, including its dynamics, trends, structure, size, growth and major suppliers.\u003c\/p\u003e\n\n\u003cp\u003eFive, year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures, including:\u003c\/p\u003e\n\n\u003cp\u003eRoutine and Special Chemistry, Microbiology\/Infectious Diseases, Hematology, Flow Cytometry, Coagulation, Immunoproteins, Drugs of Abuse, TDM, Endocrine Function, Tumor Markers\u003c\/p\u003e\n\n\u003cp\u003eSales and Market Share Analysis\u003c\/p\u003e\n\n\u003cp\u003eSales and market shares of major reagent and instrument suppliers.\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003eAnalysis of over 130 diagnostic procedures.\u003c\/p\u003e\n\n\u003cp\u003eReview of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003eEmerging technologies and their applications for physician office\/group practice diagnostic testing.\u003c\/p\u003e\n\n\u003cp\u003eComprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e\n\n\u003cp\u003eAssessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R\u0026amp;D.\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003eSpecific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eDesign criteria for POC testing products.\u003c\/p\u003e\n\n\u003cp\u003eAlternative business expansion strategies.\u003c\/p\u003e\n\n\u003cp\u003ePotential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003eMethodology\u003c\/p\u003e\n\n\u003cp\u003eThis report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ - \/ MCW16227169","offer_id":47645915054386,"sku":null,"price":5400.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2023-2027-physician-office-diagnostics-forecasts-for-300-tests-2022-supplier-shares-and-strategies-instrumentation-review-emerging-technologies-opportunities-for-suppliers","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}